Compounded Tirzepatide — 3 Month
GLP-1 / GIP dual agonist · Subscription kit
Three-month supply of compounded Tirzepatide — a dual GLP-1/GIP receptor agonist for appetite regulation and metabolic support. Saves $181 vs monthly.
- Once-weekly injectable for weight care and metabolic balance.
- All-inclusive: consultation, medication, supplies, shipping and clinician support.
- Compounded by US-licensed pharmacies.
- Not FDA-approved for treatment, cure or prevention of any disease.
Analytical specifications
| CAS Number | 2023788-19-2 |
|---|---|
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.5 |
| Appearance | Clear solution after reconstitution |
| Solubility | Soluble in bacteriostatic water |
| Storage | Refrigerate 2–8 °C |
| Purity (HPLC) | ≥99% |
Third-party verified, lot-traceable.
Every batch of Compounded Tirzepatide — 3 Month is independently analyzed via reverse-phase HPLC and Mass Spectrometry. Each vial ships with a lot number traceable to the linked COA.
Need a specific lot? Contact info@orbitrexpeptideforsale.com
For laboratory and in-vitro research only.
This product is sold strictly for laboratory and scientific research purposes. It is not a drug, food, cosmetic, or dietary supplement and is not intended for human or veterinary use, diagnostic procedures, or therapeutic application.
By placing an order, the purchaser affirms they are a qualified researcher affiliated with a licensed laboratory or academic institution, and accepts full responsibility for the safe handling, storage, and lawful use of this compound within the jurisdiction of the receiving facility.
All compounds must be handled by trained personnel using appropriate PPE in accordance with institutional safety protocols and applicable regulations. Misuse, resale, or redistribution for any unintended purpose is strictly prohibited.
Related compounds
Products sold by Orbitrex Peptides are intended solely for laboratory and scientific research purposes and are not for human or veterinary use. Purchasers affirm they are qualified researchers acting on behalf of a licensed institution.